Trials / Terminated
TerminatedNCT01552590
Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the efficacy of a 2-week course of tolvaptan in improving serum sodium and the excretion of extracellular fluid in liver cirrhotic patients with ascites and hyponatremia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tolvaptan | |
| DRUG | Placebo |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2012-03-13
- Last updated
- 2022-03-04
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01552590. Inclusion in this directory is not an endorsement.